c.h. robinson worldwide inc. - CHRW

CHRW

Close Chg Chg %
167.66 -5.56 -3.32%

Open Market

162.10

-5.56 (3.32%)

Volume: 876.31K

Last Updated:

Mar 27, 2026, 2:55 PM EDT

Company Overview: c.h. robinson worldwide inc. - CHRW

CHRW Key Data

Open

$166.95

Day Range

161.43 - 167.19

52 Week Range

84.68 - 203.34

Market Cap

$19.89B

Shares Outstanding

118.62M

Public Float

117.89M

Beta

0.90

Rev. Per Employee

N/A

P/E Ratio

34.70

EPS

$4.88

Yield

148.51%

Dividend

$0.63

EX-DIVIDEND DATE

Mar 6, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.63M

 

CHRW Performance

1 Week
 
-0.72%
 
1 Month
 
-9.50%
 
3 Months
 
1.84%
 
1 Year
 
65.79%
 
5 Years
 
71.61%
 

CHRW Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 28
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for C.h. Robinson Worldwide Inc. - CHRW

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
24.70B 17.60B 17.72B 16.23B
Sales Growth
+6.90% -28.75% +0.73% -8.42%
Cost of Goods Sold (COGS) incl D&A
22.83B 16.44B 16.39B 14.87B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
92.78M 98.98M 97.16M 102.82M
Depreciation
38.10M 39.57M 35.97M 32.52M
Amortization of Intangibles
54.67M 59.42M 61.19M 70.30M
COGS Growth
+6.20% -27.98% -0.28% -9.27%
Gross Income
1.87B 1.16B 1.33B 1.36B
Gross Income Growth
+16.27% -38.12% +15.15% +2.00%
Gross Profit Margin
+7.57% +6.58% +7.52% +8.37%
2022 2023 2024 2025 5-year trend
SG&A Expense
603.41M 604.63M 573.29M 563.38M
Research & Development
- - - -
-
Other SG&A
603.41M 604.63M 573.29M 563.38M
SGA Growth
+14.64% +0.20% -5.18% -1.73%
Other Operating Expense
- - - -
-
Unusual Expense
- - 39.46M 45.73M
-
EBIT after Unusual Expense
1.27B 513.19M 713.60M 795.88M
Non Operating Income/Expense
(22.92M) (13.80M) (48.50M) (10.32M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
77.10M 90.20M 85.90M 63.10M
Interest Expense Growth
+28.89% +16.99% -4.77% -26.54%
Gross Interest Expense
77.10M 90.20M 85.90M 63.10M
Interest Capitalized
- - - -
-
Pretax Income
1.17B 409.19M 579.20M 722.46M
Pretax Income Growth
+14.13% -64.93% +41.55% +24.73%
Pretax Margin
+4.72% +2.33% +3.27% +4.45%
Income Tax
226.24M 84.06M 113.51M 135.38M
Income Tax - Current - Domestic
186.66M 59.16M 158.89M 85.79M
Income Tax - Current - Foreign
97.15M 62.43M 32.88M 41.59M
Income Tax - Deferred - Domestic
(51.98M) (26.60M) (94.08M) 12.30M
Income Tax - Deferred - Foreign
(5.58M) (10.94M) 15.82M (4.30M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
940.52M 325.13M 465.69M 587.08M
Minority Interest Expense
- - - -
-
Net Income
940.52M 325.13M 465.69M 587.08M
Net Income Growth
+11.40% -65.43% +43.23% +26.07%
Net Margin Growth
+3.81% +1.85% +2.63% +3.62%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
940.52M 325.13M 465.69M 587.08M
Preferred Dividends
- - - -
-
Net Income Available to Common
940.52M 325.13M 465.69M 587.08M
EPS (Basic)
7.4797 2.7425 3.8871 4.8825
EPS (Basic) Growth
+17.37% -63.33% +41.74% +25.61%
Basic Shares Outstanding
125.74M 118.55M 119.81M 120.24M
EPS (Diluted)
7.397 2.7167 3.8589 4.8319
EPS (Diluted) Growth
+17.26% -63.27% +42.04% +25.21%
Diluted Shares Outstanding
127.15M 119.68M 120.68M 121.50M
EBITDA
1.36B 651.63M 856.50M 898.69M
EBITDA Growth
+15.87% -52.07% +31.44% +4.93%
EBITDA Margin
+5.51% +3.70% +4.83% +5.54%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 196.25
Number of Ratings 28 Current Quarters Estimate 1.262
FY Report Date 03 / 2026 Current Year's Estimate 6.055
Last Quarter’s Earnings 1.23 Median PE on CY Estimate N/A
Year Ago Earnings 5.09 Next Fiscal Year Estimate 7.181
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 24 24 25 25
Mean Estimate 1.26 1.53 6.05 7.18
High Estimates 1.40 1.90 6.50 8.00
Low Estimate 1.14 1.36 5.30 5.40
Coefficient of Variance 4.84 6.38 3.97 6.79

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 13 13 13
OVERWEIGHT 3 3 3
HOLD 9 9 9
UNDERWEIGHT 2 1 1
SELL 1 2 2
MEAN Overweight Overweight Overweight

Insider Actions for C.h. Robinson Worldwide Inc. - CHRW

Date Name Shares Transaction Value
Feb 20, 2026 Michael Castagnetto Pres, NAST 32,479 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.01 per share 5,716,628.79
Feb 20, 2026 Michael J. Short President, Global Forwarding 44,298 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.01 per share 7,796,890.98
Feb 20, 2026 Angela K. Freeman CHRO and ESG Officer 48,824 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.01 per share 8,593,512.24
Feb 20, 2026 Arun Rajan Chief Strat & Innov Officer 124,626 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.01 per share 21,935,422.26
Aug 13, 2025 Edward G. Feitzinger Director 1,270 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 11, 2025 Damon Lee Chief Financial Officer 37,737 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $95.17 per share 3,591,430.29
Apr 4, 2025 Michael H. McGarry Director 1,535 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Paula C. Tolliver Director 14,443 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Paige K. Robbins Director 1,535 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Henry J. Maier Director 5,733 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 James Jay Barber Director 4,315 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Timothy C. Gokey Director 22,863 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Mary J. Steele Guilfoile Director 19,620 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Mark A. Goodburn Director 9,718 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Henry Ward Winship Director 5,733 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Jodeen A. Kozlak Director 26,074 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Kermit R. Crawford Director 7,970 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

C.H. Robinson Worldwide Inc. in the News